Results 241 to 250 of about 36,481 (278)

CD39 in the pathogenesis of neuro-Behçet disease: is it an immune regulator marker? [PDF]

Front Immunol
Bahrini K, Stiti A, Boughariou S, Belghith M.   +3 more
europepmc   +1 more source

Targeting CD73 and correcting adenosinergic signaling in critically ill patients. [PDF]

Front Pharmacol
Lunderberg JM, Spicer AJ, Cassavaugh J, Jalkanen J, Haskó G, Robson SC.   +5 more
europepmc   +1 more source

The stem cell potential of bovine milk: a comparative study of colostrum and mature milk. [PDF]

Histochem Cell Biol
Delice N, Tutuncu S, Yuce M.
europepmc   +1 more source

Editorial: Community series in unraveling the molecular mechanisms of cytokine signaling in regulating inflammatory diseases, volume II. [PDF]

Front Immunol
Zheng J, Mao H, Chong WP.
europepmc   +1 more source

CD73 blockade enhances antitumor efficacy of oHSV in solid tumors by increasing macrophage-mediated antigen presentation. [PDF]

J Immunother Cancer
Murphy SA, Li J, Sahu U, Swanner J, Lewis CT, Anchang B, Cui Y, Chiocca EA, Kaur B.   +8 more
europepmc   +1 more source

Spatiotemporal dynamics of ecto-5'-nucleotidase (CD73) in mouse retina under physiological conditions. [PDF]

Development
Ishii R, Sakurai K, Hosomi N, Fleischmann BK, Mizuno S, Kimura K, Yanagisawa H.   +6 more
europepmc   +1 more source

Ecto-5'-nucleotidase/CD73 reduces COX-2 expression in activated macrophages. [PDF]

Sci Rep
Rahman MM, Sircar A, Lakhina S, Kumar P, Gupta RD, Akundi RS.   +5 more
europepmc   +1 more source

CD8 T Cell Sensing of Type I Interferon Impacts Anergy. [PDF]

Eur J Immunol
Haefke AS, Gröber H, Sandu I, Skipness V, Pantouloufos N, Gräbnitz F, Tuchel ME, Zangger N, Stark D, Kříž M, Cristinzio C, Pircher H, Spörri R, Quast I, Oxenius A.   +14 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

CD73: a potent suppressor of antitumor immune responses

Trends in Immunology, 2012
Tumors use several strategies to evade immunosurveillance. One such mechanism is the generation of adenosine within the tumor microenvironment, which potently suppresses antitumor T cell responses. Adenosine within the tumor is generated by CD73, a membrane-bound nucleotidase that is expressed by tumor cells, suppressive immune subsets such as T ...
Paul A Beavis, John Stagg, Phillip K Darcy   +2 more
exaly   +6 more sources

Functional expression of CD73 on human natural killer cells

Cancer Immunology, Immunotherapy, 2022
The production of adenosine by CD73 on cancer cells in the tumor microenvironment is a recognized immunosuppressive mechanism contributing to immune evasion in many solid tumors.
Jiao Wang, Aaron A Cohen-Gadol, Sandro Matosevic   +2 more
exaly   +2 more sources